Interleukin-25: Key regulator of inflammatory and autoimmune diseases

Current Pharmaceutical Design

Volumn 17, Issue 34, 2011, Pages 3781-3785

  Saadoun, David ^a   Terrier, Benjamin ^a   Cacoub, Patrice ^a  

^a Université Pierre et Marie Curie ^*  (France)

Author keywords

Atopic dermatitis; Churg strauss syndrome; Interleukin 13; Mast cells; Mastocytosis; T helper 17; T helper 2

Indexed keywords

EOTAXIN 2; FILAGGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 13; INTERLEUKIN 25; INTERLEUKIN 4; INTERLEUKIN 5; L SELECTIN; MESSENGER RNA; TRANSCRIPTION FACTOR JUNB; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ADAPTIVE IMMUNITY; ASTHMA; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; CELL SURVIVAL; CHURG STRAUSS SYNDROME; CYTOKINE PRODUCTION; ENTERITIS; EOSINOPHIL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATORY DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TH2 CELL;

EID: 83455238462     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211798357872     Document Type: Review

References (41)

1. Iwakura Y, Ishigame H, Saijo S, et al. Functional specialization of interleukin-17 family members. Immunity 2011; 34: 149-62.
2. Rouvier E, Luciani MF, Mattei MG, et al. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol 1993; 150: 5445-56.
3. Fort MM, Cheung J, Yen D, et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001; 15: 985-95.
4. Hibino T, Loza-Coll M, Messier C, et al. The immune gene repertoire encoded in the purple sea urchin genome. Dev Biol 2006; 300: 349-65.
5. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Dev Biol 2006; 300: 349-65.
6. Hymowitz SG, Filvaroff EH, Yin JP, et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J 2001; 20: 5332-41.
7. Hurst SD, Muchamuel T, Gorman DM, et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 2002; 169: 443-53.
8. Ikeda K, Nakajima H, Suzuki K, et al. Mast cells produce interleukin- 25 upon Fc epsilon RI-mediated activation. Blood 2003; 101: 3594-6.
9. Kang CM, Jang AS, Ahn MH, et al. Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles. Am J Respir Cell Mol Biol 2005; 33: 290-6.
10. Wang YH, Angkasekwinai P, Lu N, et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 2007; 204: 1837-47.
11. Angkasekwinai P, Park H, Wang YH, et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007; 204: 1509-17.
12. Tamachi T, Maezawa Y, Ikeda K, et al. I L-25 enhances allergicairway inflammation by amplifying a TH2 cell-dependent pathway in mice. J Allergy Clin Immunol 2006; 118: 606-14.
13. Corrigan CJ, Wang W, Meng Q, et al. T-helper cell type 2 (Th2) memory T cell-potentiating cytokine IL-25 has the potential to promote angiogenesis in asthma. Proc Natl Acad Sci USA 2011; 108: 1579-84.
14. Owyang AM, Zaph C, Wilson EH, et al. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J Exp Med 2006; 203: 843-9.
15. Kleinschek MA, Owyang AM, Joyce-Shaikh B, et al. IL-25 regulates Th17 function in autoimmune inflammation. J Exp Med 2007; 204: 161-70.
16. Cheung PF, Wong CK, Ip WK, et al. IL-25 regulates the expression of adhesion molecules on eosinophils: mechanism of eosinophilia in allergic inflammation. Allergy 2006; 61: 878-85.
17. Ballantyne SJ, Barlow JL, Jolin HE, et al. Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J Allergy Clin Immunol 2007; 120: 1324-31.
18. Fallon PG, Ballantyne SJ, Mangan NE, et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med 2006; 203: 1105-16.
19. Saenz SA, Siracusa MC, Perrigoue JG, et al. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 2010; 464: 1362-6.
20. Caruso R, Sarra M, Stolfi C, et al. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. Gastroenterology 2009; 136: 2270-9.
21. Shi Y, Ullrich SJ, Zhang J, et al. A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem 2000; 275: 19167-76.
22. Lee J, Ho WH, Maruoka M, et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem 2001; 276: 1660-4.
23. Claudio E, Sonder SU, Saret S, et al. The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J Immunol 2009; 182: 1617-30.
24. Shinkai K, Mohrs M, Locksley RM. Helper T cells regulate type-2 innate immunity in vivo. Nature 2002; 420: 825-9.
25. Voehringer D, Shinkai K, Locksley RM. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 2004; 20: 267-77.
26. Maezawa Y, Nakajima H, Suzuki K, et al. Involvement of TNF receptor-associated factor 6 in IL-25 receptor signaling. J Immunol 2006; 176: 1013-8.
27. Kim MR, Manoukian R, Yeh R, et al. Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production. Blood 2002; 100: 2330-40.
28. Sharkhuu T, Matthaei KI, Forbes E, et al. Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity. Clin Exp Allergy 2006; 36: 1575-83.
29. Hvid M, Vestergaard C, Kemp K, et al. IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction? J Invest Dermatol 2011; 131: 150-7.
30. Carmi-Levy I, Homey B, Soumelis V. A Modular View of Cytokine Networks in Atopic Dermatitis. Clin Rev Allergy Immunol, 2011; in press.
31. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951; 27: 277-301.
32. Noth I, Strek ME, Leff AR. Churg-Strauss syndrome. Lancet 2003; 361: 587-94.
33. Kiene M, Csernok E, Muller A, et al. Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome. Arthritis Rheum 2001; 44: 469-73.
34. Terrier B, Bieche I, Maisonobe T, et al. Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome. Blood 2010; 116: 4523-31.
35. Yen D, Cheung J, Scheerens H, et al. IL-23 is essential for T cellmediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006; 116: 1310-6.
36. Zaph C, Du Y, Saenz SA, et al. Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J Exp Med 2008; 205: 2191-8.
37. McHenga SS, Wang D, Li C, et al. Inhibitory effect of recombinant IL-25 on the development of dextran sulfate sodium-induced experimental colitis in mice. Cell Mol Immunol 2008; 5: 425-31.
38. McHenga SS, Wang D, Janneh FM, et al. Differential dose effects of recombinant IL-25 on the development of dextran sulfate sodium-induced colitis. Inflamm Res 2010; 59: 879-87.
39. Zhao A, Urban JF, Jr., Sun R, et al. Critical role of IL-25 in nematode infection-induced alterations in intestinal function. J Immunol 2010; 185: 6921-9.
40. Fina D, Franze E, Rovedatti L, et al. Interleukin-25 production is differently regulated by TNF-α and TGF-γ1 in the human gut. Mucosal Immunol 2011; 4: 239-44.
41. Emamaullee JA, Davis J, Merani S, et al. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009; 58: 1302-11.